Prognostic impact of heart failure admission in survivors of acute myocardial infarction

Satoshi Takeuchi,Satoshi Honda,Kensaku Nishihira,Sunao Kojima,Misa Takegami,Yasuhide Asaumi,Mike Saji,Jun Yamashita,Kiyoshi Hibi,Jun Takahashi,Yasuhiko Sakata,Morimasa Takayama,Tetsuya Sumiyoshi,Hisao Ogawa,Kazuo Kimura,Satoshi Yasuda,JAMIR Investigators
DOI: https://doi.org/10.1002/ehf2.14790
2024-05-01
ESC Heart Failure
Abstract:Aims The incidence and prognosis of symptomatic heart failure following acute myocardial infarction (AMI) in the primary percutaneous coronary intervention era have rarely been reported in the literature. This study aimed to (i) determine the incidence of heart failure admission among AMI survivors, (ii) compare 1 year outcomes between patients with heart failure admission and those without, and (iii) identify the independent risk factors associated with heart failure admission. Methods and results The Japan Acute Myocardial Infarction Registry is a prospective multicentre registry from which data on consecutively enrolled patients with AMI from 50 institutions between 2015 and 2017 were obtained. Among the 3411 patients enrolled, 3226 who survived until discharge were included in this study. The primary endpoint was all‐cause mortality. The secondary endpoints were major adverse cardiovascular events (defined as cardiovascular mortality, non‐fatal myocardial infarction, or non‐fatal cerebral infarction) and major bleeding events corresponding to Bleeding Academic Research Consortium Type 3 or 5. Clinical outcomes were compared between the patients who were and were not admitted for heart failure. Over a median follow‐up of 12 months, 124 patients (3.8%) were admitted due to heart failure. Independent risk factors for heart failure admission included older age, female sex, Killip class ≥2 on admission, left ventricular ejection fraction <40%, estimated glomerular filtration rate ≤30 mL/min/1.73 m2, a history of malignancy, and non‐use of angiotensin‐converting enzyme inhibitors at discharge. The cumulative incidence of all‐cause mortality was significantly higher in the heart failure admission group than in the no heart failure admission group (11.3% vs. 2.5%, P
cardiac & cardiovascular systems
What problem does this paper attempt to address?